Project Details
Description
EVO-NANO develops an integrated platform for the artificial evolution and validation of novel strategies for treatment of cancer using nanoparticles (NPs). We expect our proposed framework to provide a full pipeline for the development of effective NP-based therapies that are safe, have optimal bio-distribution and delivery characteristics and can be personalised to specific patients and health risks.
Acronym | EVO-NANO |
---|---|
Status | Active |
Effective start/end date | 01/10/18 → 30/09/21 |
Links | https://evonano.eu |